![Deborah Kilpatrick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Deborah Kilpatrick
Director/Board Member at
SLEEP NUMBER CORPORATION
Net worth: 32 809 $ as of 30/05/2026
Profile
Deborah L.
Kilpatrick is currently an Independent Director at Sleep Number Corp.
since 2018, Director at Sutter Health since 2024, Director at Jupiter Endovascular, Inc., Director at Dystonia Medical Research Foundation, Director at NextGen Jane, Inc., and Venture Partner at Sonder Capital Management LLC since 2024.
Former roles include Executive Chairman & Co-Chief Executive Officer at Evidation Health, Inc. from 2014 to 2024, Director-Research & Technology Development at Guidant Corp.
from 1998 to 2006, and Chief Commercial Officer at CardioDx, Inc. from 2013 to 2014.
Education includes undergraduate, graduate, and doctorate degrees from Georgia Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/05/2026 | 27,571 ( 0.12% ) | 32 809 $ | 30/05/2026 |
Deborah Kilpatrick active positions
| Companies | Position | Start |
|---|---|---|
| SLEEP NUMBER CORPORATION | Director/Board Member | 08/05/2018 |
Dystonia Medical Research Foundation | Director/Board Member | - |
NextGen Jane, Inc.
 NextGen Jane, Inc. Medical SpecialtiesHealth Technology Develops proprietary tampon systems to analyze menstrual blood | Director/Board Member | - |
Sonder Capital Management LLC
 Sonder Capital Management LLC Investment ManagersFinance Sonder Capital invests in medical technology startups located in the United States. The firm targets companies operating in the fields of life-changing healthcare technologies. It provides financing for early stage capital requirements. | Private Equity Investor | 31/12/2023 |
Sutter Health
 Sutter Health Medical/Nursing ServicesHealth Services Operates as an online healthcare networking platform | Director/Board Member | 31/12/2023 |
Former positions of Deborah Kilpatrick
| Companies | Position | End |
|---|---|---|
Evidation Health, Inc.
 Evidation Health, Inc. Packaged SoftwareTechnology Services Develops mobile application that delivers healthcare rewards points based on health performance | Chief Executive Officer | 31/12/2023 |
| CARDIODX INC | Corporate Officer/Principal | 31/12/2013 |
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Corporate Officer/Principal | 31/12/2005 |
Training of Deborah Kilpatrick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Sleep Number Corp.
 Sleep Number Corp. Home FurnishingsConsumer Durables Manufactures air and specialty mattresses | Consumer Durables |
CardioDx, Inc.
 CardioDx, Inc. Medical/Nursing ServicesHealth Services Operates as a cardiovascular genomic diagnostics company | Health Services |
Evidation Health, Inc.
Evidation Health, Inc. Packaged SoftwareTechnology Services Develops mobile application that delivers healthcare rewards points based on health performance | Technology Services |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sutter Health
Sutter Health Medical/Nursing ServicesHealth Services Operates as an online healthcare networking platform | Health Services |
Dystonia Medical Research Foundation | |
Sonder Capital Management LLC
Sonder Capital Management LLC Investment ManagersFinance Sonder Capital invests in medical technology startups located in the United States. The firm targets companies operating in the fields of life-changing healthcare technologies. It provides financing for early stage capital requirements. | Finance |
NextGen Jane, Inc.
NextGen Jane, Inc. Medical SpecialtiesHealth Technology Develops proprietary tampon systems to analyze menstrual blood | Health Technology |
- Stock Market
- Insiders
- Deborah Kilpatrick
